0001410708
2016-08-01
2017-01-31
0001410708
2017-01-31
0001410708
2016-07-31
0001410708
2016-11-20
2017-01-31
0001410708
2015-11-20
2016-01-31
0001410708
2015-08-01
2016-01-31
0001410708
2016-11-01
2017-01-31
0001410708
2015-11-01
2016-01-31
0001410708
2016-10-31
0001410708
2015-10-31
0001410708
2016-01-31
0001410708
2015-07-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
Emo Capital Corp.
0001410708
10-Q
2017-01-31
false
--07-31
No
No
No
Smaller Reporting Company
Q2
2016
21000000
35500000
0
0
46990
46990
13425
13425
60415
60415
5500
5500
26500
26500
100000
100000
-100000
-100000
-92415
-92415
-60415
-60415
0
0
0.001
0.001
125000000
125000000
35500000
35500000
0.000
0.000
0.000
0.000
35500000
35500000
35500000
35500000
<p style="margin: 0pt"></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>1. NATURE AND CONTINUANCE OF OPERATIONS</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company is a development stage company, which
was incorporated in the State of Nevada, United States of America on August 23, 2006. The Company intends to commence operations
in health and beauty care through the utilization of the web.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">These financial statements have been prepared
on a going concern basis. The Company has accumulated a deficit of $92,415 since inception and has yet to achieve profitable operations
and further losses are anticipated in the development of its business, raising substantial doubt about the Company's ability to
continue as a going concern. Its ability to continue as a going concern is dependent upon the ability of the Company to generate
profitable operations in the future and or to obtain the necessary financing to meet its obligations and repay its liabilities
arising from normal business operations when they come due. Management plans to continue to provide for its working capital needs
by seeking loans from its shareholder. These financial statements do not include any adjustments to the recoverability and classification
of assets, or the amount and classification of liabilities that may be necessary should the Company be unable to continue as a
going concern.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The company's year-end is July 31.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="margin: 0pt"></p>
<p style="margin: 0pt"></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The financial statements of the Company have been
prepared in accordance with accounting principles generally accepted in the United States of America. Because a precise determination
of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily
involves the use of estimates, which have been made using careful judgment. Actual results may vary from these estimates.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The financial statements have, in management's
opinion, been properly prepared within the framework of the significant accounting policies summarized below:</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Cash and Cash Equivalents</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">Cash equivalents comprise certain highly liquid
instruments with maturities of three months or less when purchased. As at January 31, 2017, there were Cash and Cash Equivalents
equal to $0.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Development Stage Company</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company complies with the FASB Accounting
Standards Codification (ASC) Topic 915 Development Stage Entities and the Securities and Exchange Commission Exchange Act 7 for
its characterization of the Company as development stage.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Impairment of Long Lived Assets</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">Long-lived assets are reviewed for impairment
in accordance with ASC Topic 360, "Accounting for the Impairment or Disposal of Long- lived Assets". Under ASC Topic
360, long-lived assets are tested for recoverability whenever events or changes in circumstances indicate that their carrying amounts
may not be recoverable. An impairment charge is recognized or the amount, if any, which the carrying value of the asset exceeds
the fair value.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Foreign Currency Translation</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company is located and operating outside of
the United States of America. It maintains its accounting records in U.S. Dollars, as follows:</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">At the transaction date, each asset, liability,
revenue, and expense is translated into U.S. dollars by the use of exchange rates in effect at that date. At the period end, monetary
assets and liabilities are remeasured by using the exchange rate in effect at that date. The resulting foreign exchange gains and
losses are included in operations.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company's currency exposure is insignificant
and immaterial and we do not use derivative instruments to reduce its potential exposure to foreign currency risk.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Financial Instruments</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The carrying value of the Company's financial
instruments consisting of cash equivalents and accounts payable and accrued liabilities approximates their fair value because of
the short maturity of these instruments. Unless otherwise noted, it is management's opinion that the Company is not exposed to
significant interest, currency or credit risks arising from these financial instruments.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Income Taxes</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company uses the assets and liability method
of accounting for income taxes in accordance with FASB Topic 740 “Income Taxes".  Under this method, deferred tax
assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities
are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are
expected to be recovered or settled.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Basic and Diluted Net Loss Per Share</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">In accordance with FASB Topic 260, "Earnings
Per Share', the basic net loss per common share is computed by dividing net loss available to common stockholders by the weighted
average number of common shares outstanding. Diluted net loss per common share is computed similar to basic net loss per common
share except that the denominator is increased to include the number of additional common shares that would have been outstanding
if the potential common shares had been issued and if the additional common shares were dilutive. As at January 31, 2017, diluted
net loss per share is equivalent to basic net loss per share.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Stock Based Compensation</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company accounts for stock options and similar
equity instruments issued in accordance with ASC Topic 718 Compensation-Stock Compensation.  Accordingly, compensation costs
attributable to stock options or similar equity instruments granted are measured at the fair value at the grant date, and expensed
over the expected vesting period. Transactions in which goods or services are received in exchange for the issuance of equity
instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instruments
issued, whichever is more reliably measurable. ASC Topic 718- Compensation requires excess tax benefits be reported as a financing
cash inflow rather than as a reduction of taxes paid.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company did not grant any stock options during
the period ended January 31, 2017</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Comprehensive Income</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company adopted Statement of Financial Accounting
Standards No. 130 (SFAS 130), Reporting Comprehensive Income, which establishes standards for reporting and display of comprehensive
income, its components and accumulated balances. The Company is disclosing this information on its Statement of Stockholders' Equity. 
Comprehensive income comprises equity except those resulting from investments by owners and distributions to owners. </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company has no elements of "other comprehensive
income" during the period ended January 31, 2017.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Advertising Expenses</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">There is no advertising expense incurred by the
company during the period ended January 31, 2017</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>New Accounting Standards</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">Management does not believe that any recently
issued, but not yet effective accounting standards if currently adopted could have a material effect on the accompanying financial
statements.</p>
<p style="margin: 0pt"></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Cash and Cash Equivalents</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">Cash equivalents comprise certain highly liquid
instruments with maturities of three months or less when purchased. As at January 31, 2017, there were Cash and Cash Equivalents
equal to $0.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Development Stage Company</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company complies with the FASB Accounting
Standards Codification (ASC) Topic 915 Development Stage Entities and the Securities and Exchange Commission Exchange Act 7 for
its characterization of the Company as development stage.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Impairment of Long Lived Assets</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">Long-lived assets are reviewed for impairment
in accordance with ASC Topic 360, "Accounting for the Impairment or Disposal of Long- lived Assets". Under ASC Topic
360, long-lived assets are tested for recoverability whenever events or changes in circumstances indicate that their carrying amounts
may not be recoverable. An impairment charge is recognized or the amount, if any, which the carrying value of the asset exceeds
the fair value.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Foreign Currency Translation</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company is located and operating outside of
the United States of America. It maintains its accounting records in U.S. Dollars, as follows:</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">At the transaction date, each asset, liability,
revenue, and expense is translated into U.S. dollars by the use of exchange rates in effect at that date. At the period end, monetary
assets and liabilities are remeasured by using the exchange rate in effect at that date. The resulting foreign exchange gains and
losses are included in operations.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company's currency exposure is insignificant
and immaterial and we do not use derivative instruments to reduce its potential exposure to foreign currency risk.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Financial Instruments</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The carrying value of the Company's financial
instruments consisting of cash equivalents and accounts payable and accrued liabilities approximates their fair value because of
the short maturity of these instruments. Unless otherwise noted, it is management's opinion that the Company is not exposed to
significant interest, currency or credit risks arising from these financial instruments.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Income Taxes</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company uses the assets and liability method
of accounting for income taxes in accordance with FASB Topic 740 “Income Taxes".  Under this method, deferred tax
assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities
are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are
expected to be recovered or settled.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Basic and Diluted Net Loss Per Share</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">In accordance with FASB Topic 260, "Earnings
Per Share', the basic net loss per common share is computed by dividing net loss available to common stockholders by the weighted
average number of common shares outstanding. Diluted net loss per common share is computed similar to basic net loss per common
share except that the denominator is increased to include the number of additional common shares that would have been outstanding
if the potential common shares had been issued and if the additional common shares were dilutive. As at January 31, 2017, diluted
net loss per share is equivalent to basic net loss per share.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Stock Based Compensation</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company accounts for stock options and similar
equity instruments issued in accordance with ASC Topic 718 Compensation-Stock Compensation.  Accordingly, compensation costs
attributable to stock options or similar equity instruments granted are measured at the fair value at the grant date, and expensed
over the expected vesting period. Transactions in which goods or services are received in exchange for the issuance of equity
instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instruments
issued, whichever is more reliably measurable. ASC Topic 718- Compensation requires excess tax benefits be reported as a financing
cash inflow rather than as a reduction of taxes paid.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company did not grant any stock options during
the period ended January 31, 2017</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Comprehensive Income</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company adopted Statement of Financial Accounting
Standards No. 130 (SFAS 130), Reporting Comprehensive Income, which establishes standards for reporting and display of comprehensive
income, its components and accumulated balances. The Company is disclosing this information on its Statement of Stockholders' Equity. 
Comprehensive income comprises equity except those resulting from investments by owners and distributions to owners. </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company has no elements of "other comprehensive
income" during the period ended January 31, 2017.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Advertising Expenses</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">There is no advertising expense incurred by the
company during the period ended January 31, 2017</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>New Accounting Standards</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">Management does not believe that any recently
issued, but not yet effective accounting standards if currently adopted could have a material effect on the accompanying financial
statements.</p>
<p style="margin: 0pt"></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>3. CAPITAL STOCK</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">On July 15, 2007, the Company issued 14,000,000
common shares at $0.001 per share to the sole director of the Company for total proceeds of $2,000.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">In May 2008, the Company issued 21,000,000 common
shares at $0.001 per share to subscribers for total proceeds of $30,000.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">On February 25, 2010, the Company amended its
Articles of incorporation and authorized 125,000,000 shares of common stock, at $.001 par value of which 35,000,000 were issued
and outstanding as of October 31, 2012.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">On October 31, 2010, the Stockholder's of the
Company authorized the Forward Stock Split of our issued and outstanding Common Stock on a seven for one (7:1) basis. The Forward
Stock Split became effective on October 31, 2010. As a result of the Forward Stock Split, the Company increased its issued and
outstanding shares of the Common Stock to 35,000,000 from 5,000,000.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">In May 2012, the Company subscribed 500,000 restricted
common shares at $0.20 per share to a shareholder for a subscription receivable of $100,000.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">In July 2012, the Company issued 500,000 common
shares at &0.001 per share to subscribers for total receivable proceeds of $500.</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">The number of shares outstanding of the Registrant's
common stock, par value $.001 per share, at January 31, 2017 is 35,500,000.</p>
<p style="font: 14.5pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; text-indent: 0.5in"> </p>
<p style="margin: 0pt"></p>
<p style="margin: 0pt"></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>4. RELATED PARTY TRANSACTIONS</b></p>
<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: left">A series of shareholder loans were made from August
23, 2006 to October 31, 2015 totaling $13,425. A balance of $13,425 is still outstanding as of January 31, 2017, without interest
and fixed term of repayment. The loan is due at demand.</p>
<p style="margin: 0pt"></p>